Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
42.59
-1.89 (-4.25%)
Feb 21, 2025, 4:00 PM EST - Market closed

Ultragenyx Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
-213.58132.94307.58713.53
Upgrade
Short-Term Investments
-363.63614.82432.61488.01
Upgrade
Cash & Short-Term Investments
607.51577.21747.76740.21,202
Upgrade
Cash Growth
5.25%-22.81%1.02%-38.40%59.09%
Upgrade
Accounts Receivable
-73.3940.4528.4323.09
Upgrade
Other Receivables
-1.16.4169.6
Upgrade
Receivables
-74.4946.8544.4332.69
Upgrade
Inventory
-33.9726.7716.2313.05
Upgrade
Prepaid Expenses
---55.7537.18
Upgrade
Restricted Cash
-2.010.86-10.85
Upgrade
Other Current Assets
-44.5161.66--
Upgrade
Total Current Assets
-732.18883.9856.61,295
Upgrade
Property, Plant & Equipment
-314.47285.73176.18114.04
Upgrade
Long-Term Investments
-199.9148.97293.86165.88
Upgrade
Goodwill
-44.4144.4144.4144.41
Upgrade
Other Intangible Assets
-166.27160.11130.79131.11
Upgrade
Other Long-Term Assets
-33.7922.3420.566.71
Upgrade
Total Assets
-1,4911,5451,5221,760
Upgrade
Accounts Payable
-42.1143.2717.1412.92
Upgrade
Accrued Expenses
-196.49204.68145.56108.49
Upgrade
Current Portion of Long-Term Debt
-29.24---
Upgrade
Current Portion of Leases
-12.611.7811.078.98
Upgrade
Current Unearned Revenue
--1.487.6159.22
Upgrade
Total Current Liabilities
-280.44261.21181.37189.61
Upgrade
Long-Term Debt
-862.33875.44351.79335.67
Upgrade
Long-Term Leases
-30.5719.8130.939.25
Upgrade
Long-Term Unearned Revenue
---1.477.35
Upgrade
Long-Term Deferred Tax Liabilities
-30.0631.6733.3133.31
Upgrade
Other Long-Term Liabilities
-12.214.821.01-
Upgrade
Total Liabilities
-1,2161,193599.84605.18
Upgrade
Common Stock
-0.080.070.070.07
Upgrade
Additional Paid-In Capital
-3,6623,1402,9972,773
Upgrade
Retained Earnings
--3,388-2,781-2,074-1,620
Upgrade
Treasury Stock
--0.43---
Upgrade
Comprehensive Income & Other
-1.08-6.57-1.40.69
Upgrade
Total Common Equity
346.83275.41352.49922.561,154
Upgrade
Shareholders' Equity
353.83275.41352.49922.561,154
Upgrade
Total Liabilities & Equity
-1,4911,5451,5221,760
Upgrade
Total Debt
912.5934.74907.03393.76383.89
Upgrade
Net Cash (Debt)
-101.9-157.63-10.3605.37828.15
Upgrade
Net Cash Growth
----26.90%102.96%
Upgrade
Net Cash Per Share
-1.13-2.14-0.158.9313.61
Upgrade
Filing Date Shares Outstanding
92.2882.3470.2269.3866.95
Upgrade
Total Common Shares Outstanding
92.2482.3270.269.3466.82
Upgrade
Working Capital
-451.75622.69675.241,106
Upgrade
Book Value Per Share
3.763.355.0213.3017.28
Upgrade
Tangible Book Value
137.4864.74147.98747.37978.86
Upgrade
Tangible Book Value Per Share
1.490.792.1110.7814.65
Upgrade
Land
-16.6216.6215.4911.72
Upgrade
Buildings
-181.362.8--
Upgrade
Machinery
-116.2670.2854.3141.63
Upgrade
Construction In Progress
-0.87189.4576.8517.65
Upgrade
Leasehold Improvements
-58.6843.9444.0839.36
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.